Effect of ciclesonide on quality of life in patients with moderate persistent asthma (21 to 65 y) (BY9010/AR-101)

Exclusion Criteria

• - Concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids
• - Chronic obstructive pulmonary disease (COPD)
• - Hospitalization within previous four weeks from baseline
• - Hospitalization due to asthma within the last twelve months
• - Asthma exacerbation within two months previous to baseline
• - History of almost fatal asthma at any moment
• - Pregnancy, breast feeding, intention to become pregnant during the course of the study or lack of safe contraception in pre-menopausal women
• - Exacerbation of asthma within 2 months prior to entry into the baseline period
• - Use of systemic steroids up to 2 months (injectable depot steroids 6 months) before entry into the baseline period, or more than 3 times during the last 6 months